Global

‡ In these countries please contact our distributor

CLOSER TO ZERO Wound infection

ACTICOAT

ACTICOAT dressings have a unique nanocrystalline structure for consistent delivery of silver. For use up to 7 days1-4, they are clinically effective against over 150 pathogens*2-3, 5-9 and can be bactericidal in 30 minutes*5-6, 10-11.

  

Acute burn wound management

Reduced use of antibiotics to help lower drug resistance in P.aerunginosa, with a potential 23% total treatment cost reduction**12

Download summary PDF


Partial thickness burns

May reduce hospital length of stay, infections and required surgical procedures compared to Mepilex(TM) Ag and Aquacel(TM) Ag13

Read study


Consensus

Antimicrobial dressings are an effective barrier for wounds at high risk of infection14

Download summary PDF


Patient comfort and change frequency

For use up to 7 days, minimising the trauma of dressing changes and facilitating faster healing15

Find out more


Resistance

ACTICOAT demonstrates less risk of resistance, compared with other silver dressings16

Read full study



For further information about ACTICOAT download our full product brochure.


Contact us
to discuss your requirements.


*in vitro.
**measured over 2 years.

 

This information is intended for health care professionals only.

*The decision to use Smith & Nephew products should be made by a healthcare professional, in line with applicable local protocols.  Smith & Nephew products should always be used for the indications set out in the applicable instructions for use.

 

References

1) Westaim Report Ref. #010322 ‘Seven Day Efficacy of ACTICOAT 7 Dressings Against Multiple Organisms’.
2) Driffield, K; Antimicrobial activity of ACTICOAT Flex 7 against a broad spectrum of wound pathogens, Data on file 0810012, Smith & Nephew.
3) Driffield, K; Antimicrobial activity of ACTICOAT Flex 7 dressings in a seven-day repeat challenge, Data on file 0810013, Smith & Nephew.
4) Daubney, L: Silver Release Testing of ACTICOAT Flex 7 Dressings. Report reference DS/08/062/R2.
5) Wright et al (1998) ‘Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment’, American Journal of Infection Control: 26(6):572-577.
6) Wright et al (1998) 'Efficacy of topical silver against fungal burn wound pathogens', American Journal of Infection Control (1999); 27(4): 344-350.
7) Driffield, K; Antimicrobial Activity of ACTICOAT Flex 3 against a Broad Spectrum of Wound Pathogens, Data on File reference 0810016.
8) Driffield, K; Antimicrobial activity of ACTICOAT Flex 3 in a three-day repeat challenge, Data on file 0810017, Smith & Nephew.
9) Westaim (Sherritt) Report Ref: 93/001 'Broad Spectrum Efficacy'.
10) Driffield, K; ACTICOAT Flex 3 has antimicrobial activity in 30 minutes, Data on file 0810018, Smith & Nephew.
11) Driffield, K; ACTICOAT Flex 7 has antimicrobial activity in 30 minutes, Data on file 0810014, Smith & Nephew.
12) Glik J, Łabuś W, Kitala D, et al. A 2000 patient retrospective assessment of a new strategy for burn wound management in view of infection prevention and treatment. Int Wound J. 2017 Dec 15.
13) Nherera, L et al: Silver delivery approaches in the management of partial thickness burns: A systematic review and indirect treatment comparison. Wound Rep Reg, 2017; doi: 10.1111/wrr.12559.
14) International consensus (2012): Appropriate use of silver dressings in wounds. Wounds International.
15) Upton D (2010): Pain and stress as contributors to delayed wound healing. Wound Practice and Research.
16) Chopra (2007): Increasing use of silver-based products. Jnl. Anti Chem.